Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
Gauri Mirji, Alison Worth, Sajad A. Bhat, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 100
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 77
Immunogenic PANoptosis‐Initiated Cancer Sono‐Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle
Liqiang Zhou, Jinxiao Lyu, Fang Liu, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 62
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 697-715
Closed Access | Times Cited: 54
Conditioning of the immune system by the microbiome
Daniel B. Graham, Ramnik J. Xavier
Trends in Immunology (2023) Vol. 44, Iss. 7, pp. 499-511
Open Access | Times Cited: 50
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 46
Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy
Jiaao Sun, Feng Chen, Guangzhen Wu
The ISME Journal (2023) Vol. 17, Iss. 10, pp. 1535-1551
Open Access | Times Cited: 43
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 41
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 36
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Ganoderma lucidum Polysaccharide Supplementation Significantly Activates T-Cell-Mediated Antitumor Immunity and Enhances Anti-PD-1 Immunotherapy Efficacy in Colorectal Cancer
Wenshuai Li, Qi Zhou, Bin Lv, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 21, pp. 12072-12082
Closed Access | Times Cited: 19
Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 18
The role of the gut microbiota in tumor, immunity, and immunotherapy
Yuyan Xie, Fang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
The gut microbiome and cancer response to immune checkpoint inhibitors
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2
Tumor microbiome – an integral part of the tumor microenvironment
Sona Ciernikova, Aneta Sevcikova, Viola Stevurkova, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 42
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Microbial metabolites in colorectal tumorigenesis and cancer therapy
Yali Liu, Harry Cheuk-Hay Lau, Jun Yu
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 34
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 31
The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Camille Moeckel, Katrina Bakhl, Ilias Georgakopoulos-Soares, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6710-6710
Open Access | Times Cited: 27
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Ischaemic heart disease in patients with cancer
Pietro Ameri, Edoardo Bertero, Marco Lombardi, et al.
European Heart Journal (2024) Vol. 45, Iss. 14, pp. 1209-1223
Open Access | Times Cited: 14
Clinical immunotherapy in pancreatic cancer
Xiaorong Ye, Yue Yu, Xiaohu Zheng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 4
Open Access | Times Cited: 14
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 13
Interactions between diet and gut microbiota in cancer
Geicho Nakatsu, Natalia Andreeva, M. Macdonald, et al.
Nature Microbiology (2024) Vol. 9, Iss. 7, pp. 1644-1654
Closed Access | Times Cited: 11
The gut microbiota derived metabolite trimethylamine N-oxide: Its important role in cancer and other diseases
Yuhua Zhou, Yuwei Zhang, Shengkai Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117031-117031
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top